[Bitop市场观察] ETC、NEAR做空良机 加密货币精准点位+止盈止损分享(新手必看)

金色财经Publicado a 2025-08-19Actualizado a 2025-08-19

ETC

spacer.gif

ETC于四小时级别观察倒头肩顶型态,价格在触及颈线后反弹,并于21.83美元受阻拉回。撰稿当下暂报21.5美元,投资人可趁此机会进场做空。止盈目标可设于20.2、20、19.3美元。止损则依照个人风险承担能力,介于22.1至22.35之间。

参考点位:

方向:空

进场:$21.5

止盈:$20 / $20.2 / $19.3

止损:$22.1 / $22.35

NEAR

spacer.gif

NEAR同ETC也形成头肩顶型态。价格跌破颈线后于2.54美元附近反弹拉回,撰稿当下暂报2.55美元。

投资人可选择市价进场做空或等待价格向上测试压力再进场。进场价位介于2.65至2.69美元之间。止盈目标可分批设于2.45、2.4、2.25美元。止损则设于2.75美元。

参考点位:

方向:空

进场:$2.55 (市价) / $2.65 - $2.69

止盈:$2.45 / $2.4 / $2.25

止损:$2.75

POL

spacer.gif

POL昨日带量大幅上涨,今日早上八点左右顺势突破大型三角形,并于0.2677美元附近受阻拉回。预计价格可能向下测试支撑区间,若成功站住可趁此机会做多。进场价位介于0.248至0.253美元之间。止萤幕标可分批设于0.278、0.292、0.308美元。止损则依照个人风险承担能力,介于0.239至0.232美元之间。

参考点位:

方向:多

进场:$$0.248 - $0.253

止盈:$0.278 / $0.292 / $0.308

止损:$$0.239 - $0.232

 

本文由bitop市场观察团队分析师编撰,内容仅为个人观点分享,不构成相关的任何投资建议。分析有时效性,投资有风险,入市需谨慎 !

Criptos en tendencia

Lecturas Relacionadas

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbitHace 34 min(s)

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbitHace 34 min(s)

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbitHace 34 min(s)

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbitHace 34 min(s)

Trading

Spot

Artículos destacados

Cómo comprar NEAR

¡Bienvenido a HTX.com! Hemos hecho que comprar NEAR Protocol (NEAR) sea simple y conveniente. Sigue nuestra guía paso a paso para iniciar tu viaje de criptos.Paso 1: crea tu cuenta HTXUtiliza tu correo electrónico o número de teléfono para registrarte y obtener una cuenta gratuita en HTX. Experimenta un proceso de registro sin complicaciones y desbloquea todas las funciones.Obtener mi cuentaPaso 2: ve a Comprar cripto y elige tu método de pagoTarjeta de crédito/débito: usa tu Visa o Mastercard para comprar NEAR Protocol (NEAR) al instante.Saldo: utiliza fondos del saldo de tu cuenta HTX para tradear sin problemas.Terceros: hemos agregado métodos de pago populares como Google Pay y Apple Pay para mejorar la comodidad.P2P: tradear directamente con otros usuarios en HTX.Over-the-Counter (OTC): ofrecemos servicios personalizados y tipos de cambio competitivos para los traders.Paso 3: guarda tu NEAR Protocol (NEAR)Después de comprar tu NEAR Protocol (NEAR), guárdalo en tu cuenta HTX. Alternativamente, puedes enviarlo a otro lugar mediante transferencia blockchain o utilizarlo para tradear otras criptomonedas.Paso 4: tradear NEAR Protocol (NEAR)Tradear fácilmente con NEAR Protocol (NEAR) en HTX's mercado spot. Simplemente accede a tu cuenta, selecciona tu par de trading, ejecuta tus trades y monitorea en tiempo real. Ofrecemos una experiencia fácil de usar tanto para principiantes como para traders experimentados.

409 Vistas totalesPublicado en 2024.12.10Actualizado en 2026.06.02

Cómo comprar NEAR

Discusiones

Bienvenido a la comunidad de HTX. Aquí puedes mantenerte informado sobre los últimos desarrollos de la plataforma y acceder a análisis profesionales del mercado. A continuación se presentan las opiniones de los usuarios sobre el precio de NEAR (NEAR).

活动图片